Gene · 1672
Papers3,189
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 3,189
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Development of a PET Probe Targeting Bromodomain and Extra-Terminal Proteins for In Vitro and In Vivo Visualization. | Pharmaceuticals (Basel) | 2024 | 39770515 | PubTator, text mining | PubMed |
| Docking‑based virtual screening of BRD4 (BD1) inhibitors: assessment of docking methods, scoring functions and in silico molecular properties. | BMC Chem | 2024 | 39696643 | PubTator, text mining | PubMed |
| BODIPYS Based Fluorescent Markers To Monitor Autophagic Lysosomes and Lipid Droplets in TNBC. | ACS Med Chem Lett | 2024 | 39691523 | PubTator, text mining | PubMed |
| β-Defensin versus conventional markers of inflammation in periprosthetic joint infection: a retrospective study. | PeerJ | 2024 | 39575176 | PubTator, text mining | PubMed |
| [New Prospects for Conservative Treatment of Chronic Recurrent Cystitis in Women: Experience with the Drug Superlymph]. | Urologiia | 2024 | 39563583 | PubTator, text mining | PubMed |
| Molecular mechanisms underlying roles of long non-coding RNA small nucleolar RNA host gene 16 in digestive system cancers. | World J Gastrointest Oncol | 2024 | 39554746 | PubTator, text mining | PubMed |
| Isoleucine Enhanced the Function of the Small Intestinal Mucosal Barrier in Weaned Piglets to Alleviate Rotavirus Infection. | Animals (Basel) | 2024 | 39518871 | PubTator, text mining | PubMed |
| Targeted protein degradation: advances in drug discovery and clinical practice. | Signal Transduct Target Ther | 2024 | 39500878 | PubTator, text mining | PubMed |
| The Development and Evaluation of a Novel Highly Selective PET Radiotracer for Targeting BET BD1. | Pharmaceuticals (Basel) | 2024 | 39458928 | PubTator, text mining | PubMed |
| Gene expression responses of CF airway epithelial cells exposed to elexacaftor/tezacaftor/ivacaftor suggest benefits beyond improved CFTR channel function. | Am J Physiol Lung Cell Mol Physiol | 2024 | 39437760 | PubTator, text mining | PubMed |
| A "Goldilocks Zone" for Recruiting BET Proteins with Bromodomain-1-Selective Ligands. | ACS Chem Biol | 2024 | 39401417 | PubTator, text mining | PubMed |
| Polymorphic variation of the DEFB1 gene might contribute to the development of ankylosing spondylitis: a preliminary study. | Mol Biol Rep | 2024 | 39395079 | PubTator, text mining | PubMed |
| Epithelial Antimicrobial Peptide/Protein and Cytokine Expression Profiles Obtained from Nasopharyngeal Swabs of SARS-CoV-2-Infected and Non-Infected Subjects. | Viruses | 2024 | 39339947 | PubTator, text mining | PubMed |
| Association between DEFB1 rs11362 and Caries Susceptibility in Permanent Dentition: A Cross Sectional Study. | Discov Med | 2024 | 39327247 | PubTator, text mining | PubMed |
| Gene expression responses of CF airway epithelial cells exposed to elexacaftor/tezacaftor/ivacaftor (ETI) suggest benefits beyond improved CFTR channel function. | bioRxiv | 2024 | 39257747 | PubTator, text mining | PubMed |
| Tumor-derived DEFB1 induces immune tolerance by inhibiting maturation of dendritic cell and impairing CD8+ T cell function in esophageal squamous cell carcinoma. | Chin J Cancer Res | 2024 | 39246704 | PubTator, text mining | PubMed |
| Preliminary study on the role of human defensins, interleukins and PCSK9 in early and late preeclampsia. | Reprod Biol | 2024 | 39232305 | PubTator, text mining | PubMed |
| Development and Evaluation of [11C]I-58: A Novel PET Radiotracer Targeting BRD4 BD2 for Advanced Epigenetic Imaging. | ACS Omega | 2024 | 39220497 | PubTator, text mining | PubMed |
| Navigating the labyrinth of long non-coding RNAs in colorectal cancer: From chemoresistance to autophagy. | World J Gastrointest Oncol | 2024 | 39171173 | PubTator, text mining | PubMed |
| Restoration of the Lost Human Beta Defensin-1 Protein in Cancer as a Strategy to Improve the Efficacy of Chemotherapy. | J Med Chem | 2024 | 39137365 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1672/papers?page=7